Additive Benefit of the Urine LAM Test to Current TB Diagnostics in HIV Positive Adults in Panama City, Panama | MicrobiomeTrials← Back to trialsNCT02911740
Additive Benefit of the Urine LAM Test to Current TB Diagnostics in HIV Positive Adults in Panama City, Panama
WITHDRAWNNAINTERVENTIONAL
Trial Details
Start: 2017-11Est. Completion: 2018-08
Enrollment target: 0 participants Other microbiome trials you might be interested in
Ulcerative ColitisCrohn's Disease
More older people (more than 65 years of age) around the world are getting Ulcerative Colitis (UC) or Crohn's Disease (C…
Cambridge, United StatesEst. completion Dec 15, 2026
HIV-1-infection
Phase III trial evaluating doravirine as an alternative to dolutegravir in treatment naïve people living with HIV-1 infe…
Nova Iguaçu, BrazilEst. completion Jan 2028
Recruiting
TuberculosisTuberculosis, PulmonaryTuberculosis, Lymph NodeMycobacterium Tuberculosis
While drug-susceptible tuberculosis (TB) disease in children currently requires four to six months of treatment, most ch…
Chennai, IndiaEst. completion Sep 30, 2027